Dr. Ian M. Cawich, MD

Dr. Cawich practices at Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital.

Dr. Cawich's NPI, 1427273432, was assigned on April 16, 2007. Dr. Cawich graduated from University of Arkansas College of Medicine in 2001. Dr. Cawich holds Arkansas license E4068.

Dr. Cawich's primary practice is Arkansas Heart Hospital, at 1701 S Shackleford Road, Little Rock, AR 72211 in Pulaski County. The practice phone is (501) 219-7000.

Dr. Cawich's primary practice is Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital. Dr. Cawich is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is Arkansas Heart Hospital Clinic (Little Rock Clinic). Dmand AI also links Dr. Cawich to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cawich practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cawich's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cawich is licensed in Arkansas.

CMS data shows 3,018 Medicare services from Dr. Cawich across 44 procedure codes in 2024, for 746 Medicare patients. Medicare paid $243,303 for them.

CMS counts 746 Medicare patients who saw Dr. Cawich in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cawich's median patient age at 74, with 53% women.

In 2024, Dr. Cawich wrote 4,786 Medicare Part D claims for 674 patients. 88% of them were for generic drugs. CMS names the drug for 4,565 of them, across 50 drugs with 11 or more claims each, at $400,498 in total drug cost. In 2023, CMS named 4,399 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cawich for performance year 2024, reported as part of a group. Dr. Cawich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 78 procedures of leg revascularization (restoring blood flow) by Dr. Cawich, more than 98% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Cawich, published from 2013 to 2022. 2013 was the busiest year, with 3. The most frequent topics are Peripheral Arterial Disease, Amputation, Surgical and Endovascular Procedures. Dr. Cawich has published most often in Cardiovasc Revasc Med. Dr. Cawich's most frequent co-authors are Vasili Lendel, MD, Konstantinos Marmagkiolis, MD and Ehrin J. Armstrong, MD.

Dmand AI links Dr. Cawich to 8 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia. Mercator MedSystems, Inc. sponsors the most, 3.

CMS Open Payments shows 1,238 general payments to Dr. Cawich from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 33% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $124,618.

Dr. Cawich graduated from University of Arkansas College of Medicine in 2001.